Telomerase activity levels in the surgical margin and tumour distant tissue of the squamous cell carcinoma of the head-and-neck

被引:18
作者
Fabricius, EM
Gurr, U
Wildner, GP
机构
[1] Humboldt Univ, Fac Med, Clin Oral & Maxillofacial Surg, Charite, D-13353 Berlin, Germany
[2] Humboldt Univ, Fac Med, Charite, Robert Rossle Clin,Dept Pathol, D-13353 Berlin, Germany
关键词
head-and-neck cancer; squamous cell carcinoma; surgical tumour margin; telomerase; TRAP assay; ELISA;
D O I
10.1155/2002/452527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The survival of patients with a head-and-neck squamous cell carcinoma is determined by loco-regional recurrence and second primary carcinomas. As a complement to histopathology, molecular changes of tumour marginal and tumour distant tissue may confirm curative surgical tumour extirpation. We tested telomerase activity with PCR-ELISA kits. 20 tumour margin biopsies were chosen by the surgeon from 20 patients. In addition, 3 tissue samples were taken from each of 20 additional patients, one from the carcinoma centre, the tumour margin and one distant from the tumour. 50% of the carcinoma centres were telomerase-positive. Thirteen of the 40 tumour margin samples showed increased telomerase levels, and in 3 of these residual carcinoma was histopathologically detected. Six of the 20 tumour distant tissues revealed increased telomerase levels. Telomerase positivity in carcinoma-free tumour margins correlated with a good prognosis. Confirmation of the results in a larger patient group is needed.
引用
收藏
页码:25 / 39
页数:15
相关论文
共 108 条
[71]  
Partridge M, 2000, CLIN CANCER RES, V6, P2718
[72]   Evaluation of telomerase activation in head and neck cancer [J].
Patel, MM ;
Patel, DD ;
Parekh, LJ ;
Raval, GN ;
Rawal, RM ;
Bhatavdekar, JM ;
Patel, BP ;
Patel, PS .
ORAL ONCOLOGY, 1999, 35 (05) :510-515
[73]  
*R KOCH I DEUTSCHL, 1999, HAUF TRENDS, V2, P1
[74]  
Ries JC, 2001, ANTICANCER RES, V21, P1057
[75]  
SACHS L, 1991, ANGEWANDTE STAT ANWE, P1
[76]   MUTAGEN SENSITIVITY IN PATIENTS WITH HEAD AND NECK CANCERS - A BIOLOGIC MARKER FOR RISK OF MULTIPLE PRIMARY MALIGNANCIES [J].
SCHANTZ, SP ;
SPITZ, MR ;
HSU, TC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (22) :1773-1775
[77]   Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers [J].
Schantz, SP ;
Huang, Q ;
Shah, K ;
Murty, VVVS ;
Hsu, TC ;
Yu, GP ;
Andersen, PE ;
Huvos, AG ;
Chaganti, RSK .
CARCINOGENESIS, 2000, 21 (06) :1239-1246
[78]  
Scholes AGM, 1998, CANCER RES, V58, P2003
[79]   The reactivation of telomerase activity in cancer progression [J].
Shay, JW ;
Wright, WE .
TRENDS IN GENETICS, 1996, 12 (04) :129-131
[80]   A survey of telomerase activity in human cancer [J].
Shay, JW ;
Bacchetti, S .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (05) :787-791